Peter Wallace Stacpoole
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.7MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 7, 2022 | NIH | STTR Phase II Personalized dosing of dichloroacetate for the treatment of rare and common diseases | $985K | Medosome Biotec, LLC |
| Aug 18, 2021 | NIH | STTR Phase II Personalized dosing of dichloroacetate for the treatment of rare and common diseases | $993K | Medosome Biotec, LLC |
| Sep 10, 2018 | NIH | STTR Phase II Personalized dosing of dichloroacetate for the treatment of rare and common diseases | $695K | Medosome Biotec, LLC |
| Jun 28, 2017 | NIH | STTR Phase II Personalized dosing of dichloroacetate for the treatment of rare and common diseases | $794K | Medosome Biotec, LLC |
| Sep 13, 2016 | NIH | STTR Phase II Personalized dosing of dichloroacetate for the treatment of rare and common diseases | $225K | Medosome Biotec, LLC |
Peer ranks
Federal funding#448
Awards as PI#417
Patents#273
Companies
- Medosome Biotec, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.